Nadege Anizan

Villejuif, 94805, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Lesional dosimetry in 131I refractory metastatic differentiated thyroid cancer with BRAFp.V600E or RAS mutation treated with trametinib +/- dabrafenib followed by radioactive iodine.

Lesional dosimetry in 131I refractory metastatic differentiated thyroid cancer with BRAFp.V600E or RAS mutation treated with trametinib +/- dabrafenib followed by radioactive iodine.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
Published: July 03, 2025

Quantification in respiratory-gated PET acquisition: can data-driven methods replace device-based systems?-a comparative and retrospective study.

Quantification in respiratory-gated PET acquisition: can data-driven methods replace device-based systems?-a comparative and retrospective study.

Journal: EJNMMI research
Published: September 17, 2024

MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer.

MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer.

Journal: Thyroid : official journal of the American Thyroid Association
Published: June 23, 2023

A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.

A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 12, 2023

Patient-specific biokinetics and hybrid 2D/3D approach integration in OEDIPE software: Application to radioiodine therapy.

Patient-specific biokinetics and hybrid 2D/3D approach integration in OEDIPE software: Application to radioiodine therapy.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
Published: March 08, 2022

Redifferentiation-facilitated radioiodine therapy in thyroid cancer.

Redifferentiation-facilitated radioiodine therapy in thyroid cancer.

Journal: Endocrine-related cancer
Published: March 04, 2021

Cleaved CD31 as a target for in vivo molecular imaging of inflammation.

Cleaved CD31 as a target for in vivo molecular imaging of inflammation.

Journal: Scientific reports
Published: September 12, 2019

Nanostructured lipid carriers accumulate in atherosclerotic plaques of ApoE-/- mice.

Nanostructured lipid carriers accumulate in atherosclerotic plaques of ApoE-/- mice.

Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: June 18, 2019

Early angiogenesis detected by PET imaging with 64Cu-NODAGA-RGD is predictive of bone critical defect repair.

Early angiogenesis detected by PET imaging with 64Cu-NODAGA-RGD is predictive of bone critical defect repair.

Journal: Acta biomaterialia
Published: July 14, 2018

Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept.

Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept.

Journal: EJNMMI research
Published: February 27, 2017

dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system.

dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system.

Journal: EJNMMI research
Published: October 07, 2011
Showing 1-11 of 11

Last Updated: 09/26/2026